{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:32:54Z","timestamp":1717115574724},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,29]]},"DOI":"10.7759\/cureus.61328","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T01:39:06Z","timestamp":1717033146000},"source":"Crossref","is-referenced-by-count":0,"title":["Mind the Anion Gap: 5-Oxoproline-Induced High Anion Gap Metabolic Acidosis in End-Stage Renal Disease"],"prefix":"10.7759","author":[{"given":"Danny","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Seu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvester","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2016.1166533","article-title":"The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetase in vitro; a clue to the mechanism of 5-oxoprolinuric acidosis?","volume":"47","author":"Walker V","year":"2017","unstructured":"Walker V, Mills GA, Anderson ME, et al.. The acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI) inhibits glutathione synthetase in vitro; a clue to the mechanism of 5-oxoprolinuric acidosis?. Xenobiotica. 2017, 47:164-75. 10.3109\/00498254.2016.1166533","journal-title":"Xenobiotica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004351","article-title":"Malnourishment-associated acetaminophen toxicity in pregnancy","volume":"137","author":"Dom AM","year":"2021","unstructured":"Dom AM, Royzer R, Olson-Chen C. Malnourishment-associated acetaminophen toxicity in pregnancy. Obstet Gynecol. 2021, 137:877-80. 10.1097\/AOG.0000000000004351","journal-title":"Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2013.844822","article-title":"What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?","volume":"51","author":"Liss DB","year":"2013","unstructured":"Liss DB, Paden MS, Schwarz ES, Mullins ME. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?. Clin Toxicol (Phila). 2013, 51:817-27. 10.3109\/15563650.2013.844822","journal-title":"Clin Toxicol (Phila)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318259bd45","article-title":"Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation","volume":"344","author":"Zand L","year":"2012","unstructured":"Zand L, Muriithi A, Nelsen E, Franco PM, Greene EL, Qian Q, El-Zoghby ZM. Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation. Am J Med Sci. 2012, 344:501-4. 10.1097\/MAJ.0b013e318259bd45","journal-title":"Am J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/CLINCHEM\/35.4.684","article-title":"Pyroglutamic acidemia in an adult patient","volume":"35","author":"Creer MH","year":"1989","unstructured":"Creer MH, Lau BW, Jones JD, Chan KM. Pyroglutamic acidemia in an adult patient. Clin Chem. 1989, 35:684-6. 10.1093\/CLINCHEM\/35.4.684","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07730713","article-title":"Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle","volume":"9","author":"Emmett M","year":"2014","unstructured":"Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol. 2014, 9:191-200. 10.2215\/CJN.07730713","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01799581","article-title":"Atypical pyroglutamic aciduria: possible role of paracetamol","volume":"13","author":"Pitt JJ","year":"1990","unstructured":"Pitt JJ, Brown GK, Clift V, Christodoulou J. Atypical pyroglutamic aciduria: possible role of paracetamol. J Inherit Metab Dis. 1990, 13:755-6. 10.1007\/BF01799581","journal-title":"J Inherit Metab Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01411005","article-title":"Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen","volume":"1","author":"Fenves AZ","year":"2006","unstructured":"Fenves AZ, Kirkpatrick HM 3rd, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol. 2006, 1:441-7. 10.2215\/CJN.01411005","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman HJ","year":"2009","unstructured":"Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009, 30:1-12. 10.1016\/j.mam.2008.08.006","journal-title":"Mol Aspects Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb01812.x","article-title":"Kinetics and metabolism of paracetamol and phenacetin","volume":"10","author":"Prescott LF","year":"1980","unstructured":"Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980, 10:291S-8S. 10.1111\/j.1365-2125.1980.tb01812.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01143.x","article-title":"What do we (not) know about how paracetamol (acetaminophen) works?","volume":"35","author":"Toussaint K","year":"2010","unstructured":"Toussaint K, Yang XC, Zielinski MA, Reigle KL, Sacavage SD, Nagar S, Raffa RB. What do we (not) know about how paracetamol (acetaminophen) works?. J Clin Pharm Ther. 2010, 35:617-38. 10.1111\/j.1365-2710.2009.01143.x","journal-title":"J Clin Pharm Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.946994","article-title":"Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup","volume":"52","author":"Gosselin S","year":"2014","unstructured":"Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, Hoffman RS. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014, 52:856-67. 10.3109\/15563650.2014.946994","journal-title":"Clin Toxicol (Phila)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu SC","year":"2009","unstructured":"Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009, 30:42-59. 10.1016\/j.mam.2008.05.005","journal-title":"Mol Aspects Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2009.033","article-title":"Glutathione dysregulation and the etiology and progression of human diseases","volume":"390","author":"Ballatori N","year":"2009","unstructured":"Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009, 390:191-214. 10.1515\/BC.2009.033","journal-title":"Biol Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/258360-mind-the-anion-gap-5-oxoproline-induced-high-anion-gap-metabolic-acidosis-in-end-stage-renal-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T01:39:08Z","timestamp":1717033148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/258360-mind-the-anion-gap-5-oxoproline-induced-high-anion-gap-metabolic-acidosis-in-end-stage-renal-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.61328","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,29]]}}}